Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
Br J Cancer. 2018 Apr;118(8):1074-1083. doi: 10.1038/s41416-018-0050-9. Epub 2018 Mar 26.
Br J Cancer. 2018.
PMID: 29576625
Free PMC article.
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.
Franceschini N, Oosting J, Tamsma M, Niessen B, Bruijn IB, van den Akker B, Kruisselbrink AB, Palubeckaitė I, Bovée JVMG, Cleton-Jansen AM.
Franceschini N, et al. Among authors: niessen b.
Int J Mol Sci. 2021 Jun 10;22(12):6273. doi: 10.3390/ijms22126273.
Int J Mol Sci. 2021.
PMID: 34200964
Free PMC article.
Item in Clipboard
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.
Peterse EFP, van den Akker BEWM, Niessen B, Oosting J, Suijker J, de Jong Y, Danen EHJ, Cleton-Jansen AM, Bovée JVMG.
Peterse EFP, et al. Among authors: niessen b.
Mol Cancer Res. 2017 Dec;15(12):1714-1721. doi: 10.1158/1541-7786.MCR-17-0293. Epub 2017 Aug 31.
Mol Cancer Res. 2017.
PMID: 28860121
Item in Clipboard
Cite
Cite